A real-world cost-effectiveness study of vancomycin versus linezolid for the treatment of late-onset neonatal sepsis in the NICU in China

• Main Authors: Linjun Xie (Author), Leyun Ding (Author), Lian Tang (Author), Zuming Yang (Author), Dan Wu (Author), Wenjuan Wang (Author), Juehui Mao (Author), Lu Shi (Author), Chun Liu (Author), Lufen Duan (Author), Jinhui Xu (Author), Qin Zhou (Author), Jiantong Sun (Author), Xinyuan Ding (Author)
• Format: Book
• Published: BMC, 2023-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background and objective Currently, the detection rates of methicillin-resistant S. aureus (MRSA) and methicillin-resistant coagulase-negative staphylococci (MRCoNS) in the blood cultures of neonates with sepsis exceed the national average drug resistance level, and vancomycin and linezolid...